The public registers hold a second record for Reyoung Pharmaceutical. The fuller profile, with 9 active US DMFs and 0 valid CEPs, is at Reyoung Pharmaceutical. Figures on this page cover only this record.
Reyoung Pharmaceutical is a finished-dose manufacturer based in China. It appears in 261 regulatory filings across 11 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC), DIGEMAPS (DO) and NAFDAC (NG). Its GMP standing is certified by ANVISA (Brazil), EMA and INVIMA (CO), among 5 authorities.
| Site | FDA FEI |
|---|---|
| SHANDONG, China | Not on file |
| Zibo, China | Not on file |
| Shandong, Colombia | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 78 | None |
| DIGEMAPS (DO) | 56 | None |
| NAFDAC (NG) | 40 | None |
| MINSA (CR) | 31 | None |
| EFDA (ET) | 25 | None |
| UZPHARM (UZ) | 21 | 2 |
| ANVISA (Brazil) | None | 4 |
| EMA | None | 2 |
| INVIMA (CO) | None | 2 |
| MFDS (Korea) | None | 2 |
Choose your molecules and target markets. Reyoung Pharmaceutical comes back tiered against every other supplier able to file there.
Start for free